Skip to main content

Perioperative infection prediction


Some 50M people need to undergo inpatient surgery per year in Europe Yet, despite intensive research efforts, around 25% of surgical patients will experience a complicated recovery with some type of infection on their path: pneumonia, urinary tract infections, wound infections, abdominal infections and bacteremia. Of course, the risk varies depending on the patient and the procedure, but despite efforts like biomarkers, risk scores or devices for early warning/detection, and preventive methods like ‘Enhanced Recovery After Surgery’ (ERAS), the overall risk still leaves almost one in four patients to get an infection within 30-days after surgery.

If we look beyond the personal suffering of patients and relatives, the cost of an infectious complication is estimated at around €10,000 per patient. Hence, total cost in only the Netherlands alone can be calculated at up to €3.5B per year, as approximately 350,000 Dutch patients go through an infection after surgery yearly. Total EU costs are even more shocking at an estimated €125B per year. R&D BV is currently developing an advanced machine-learning (ML) algorithm (TRL level 4) to predict post-operative infections 5 days prior to the average medical team diagnosis, currently already achieving an accuracy of 80%. Through increasing the dataset and taking on more types of data, the ultimate goal is to ultimately achieve >90% accuracy at 5 days before the infectious symptoms on average are actually detected within the patient.

In this proposal, we seek how to go beyond the proven technical feasibility and assess channels to deliver the tool in a safe, affordable and scalable way through third-party vendors with a sustainable business model and plan with the right partnerships and intensify these relationships. Also, potential legal and regulatory issues with EU expansion will be identified, investigated and suitable measures outlined.

Field of science

  • /social sciences/economics and business/business and management/business model
  • /medical and health sciences/clinical medicine/surgery
  • /social sciences/economics and business/economics/sustainable economy

Call for proposal

See other projects for this call

Funding Scheme

SME-1 - SME instrument phase 1


Singel 542
1017 AZ Amsterdam
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
EU contribution
€ 50 000